Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT05054413

Conditions

Hematopoietic and Lymphoid Cell Neoplasm

Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Accepted

Interventions

Questionnaire Administration

Study Details

Brief summary:

This study formulates consensus agreement on clinical key elements related to prostate cancer care that are critical for standardization and global reported using a robust Delphi technique, completely remote and electronic. The goal of this survey study is to have a panel of specialty-specific experts create a consensus agreement on a minimum set of key data elements for use in standardized reports. These recommendations would be used to develop standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivorship.

Conditions

Hematopoietic and Lymphoid Cell Neoplasm

Malignant Solid Neoplasm

Study ID

NCT05054413

Start date

Apr 15, 2021

Status verified date

May, 2026

Completion date

Aug 1, 2030

Anticipated

Primary completion date

Aug 1, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Age 21 and above
  • Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology
  • Maintenance of an active practice that includes prostate cancer patients
  • English speaking

Exclusion Criteria:

  • Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer
  • Prisoners, children, and adults unable to consent to participation will also be excluded
  • No exclusions were made based on sex, age, racial/ethnic background, or pregnancy status

Study Design

Enrollment

10 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational (questionnaire)

Participants complete 3-4 rounds of questionnaires over 20-30 minutes each over 2 weeks.

Interventions

Questionnaire Administration

Complete questionnaires

Primary outcome measure

  • To establish a standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivor-ship. [ Time Frame: through study completion, an average of a year. ]

Central Contacts and Locations

Central contacts

Amy C Moreno

713-745-4590akmoreno@mdanderson.org

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Amy C. Moreno

832-728-6162akmoreno@mdanderson.org

Principal Investigator:

Amy C. Moreno

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

May 26, 2026

Last verified

May, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-05-26.